This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Apollo Endosurgery Past Earnings Performance
Past criteria checks 0/6
Key information
3.0%
Earnings growth rate
21.2%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 1.9% |
| Return on equity | -122.2% |
| Net Margin | -51.8% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Apollo Endosurgery makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 77 | -40 | 57 | 12 |
| 30 Sep 22 | 72 | -41 | 53 | 11 |
| 30 Jun 22 | 68 | -36 | 50 | 11 |
| 31 Mar 22 | 66 | -28 | 47 | 10 |
| 31 Dec 21 | 63 | -25 | 43 | 10 |
| 30 Sep 21 | 60 | -18 | 39 | 9 |
| 30 Jun 21 | 56 | -14 | 35 | 8 |
| 31 Mar 21 | 45 | -17 | 28 | 7 |
| 31 Dec 20 | 42 | -23 | 28 | 8 |
| 30 Sep 20 | 41 | -26 | 31 | 8 |
| 30 Jun 20 | 40 | -32 | 34 | 8 |
| 31 Mar 20 | 48 | -35 | 41 | 9 |
| 31 Dec 19 | 51 | -27 | 42 | 10 |
| 30 Sep 19 | 54 | -39 | 44 | 11 |
| 30 Jun 19 | 57 | -40 | 45 | 13 |
| 31 Mar 19 | 58 | -40 | 45 | 13 |
| 31 Dec 18 | 61 | -46 | 46 | 12 |
| 30 Sep 18 | 62 | -35 | 46 | 11 |
| 30 Jun 18 | 64 | -30 | 47 | 10 |
| 31 Mar 18 | 66 | -27 | 47 | 9 |
| 31 Dec 17 | 64 | -27 | 47 | 8 |
| 30 Sep 17 | 64 | -33 | 44 | 9 |
| 30 Jun 17 | 63 | -36 | 44 | 9 |
| 31 Mar 17 | 63 | -41 | 43 | 8 |
| 31 Dec 16 | 65 | -41 | 42 | 8 |
| 30 Sep 16 | 66 | -36 | 43 | 7 |
| 30 Jun 16 | 66 | -38 | 44 | 8 |
Quality Earnings: APEN is currently unprofitable.
Growing Profit Margin: APEN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: APEN is unprofitable, but has reduced losses over the past 5 years at a rate of 3% per year.
Accelerating Growth: Unable to compare APEN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: APEN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.1%).
Return on Equity
High ROE: APEN has a negative Return on Equity (-122.23%), as it is currently unprofitable.